Bleomycin

Uses your system voice; voice and rate in settings.

Snapshot

≈ 6 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 401932982 | image = Bleomycin A2.svg | image_class = skin-invert-image | caption = Bleomycin A2 | width = 350 | alt = | pronounce = | tradename = Blenoxane | Drugs.com = | MedlinePlus = a682125 | DailyMedID = Bleomycin | pregnancy_AU = D | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = intravenous, intramuscular, subcutaneous, intrapleural | class = Glycopeptide antibiotic | ATC_prefix = L01 | ATC_suffix = DC01 | ATC_supplemental = | legal_AU = S4 | legal_AU_comment = | legal_BR = | legal_BR_comment = | legal_CA = | legal_CA_comment = | legal_DE = | legal_DE_comment = | legal_NZ = | legal_NZ_comment = | legal_UK = POM | legal_UK_comment = | legal_US = Rx-only | legal_US_comment = | legal_EU = Rx-only | legal_EU_comment = | legal_UN = | legal_UN_comment = | legal_status = | bioavailability = 100% and 70% following intramuscular and subcutaneous administrations, respectively, and 45% following both intraperitoneal and intrapleural administrations | protein_bound = | metabolism = | metabolites = | onset = | elimination_half-life = two hours | duration_of_action = | excretion = Kidney (60–70%) | index_label = | index2_label = sulfate | CAS_number_Ref = | CAS_number = 11056-06-7 | CAS_number2_Ref = | CAS_number2 = 9041-93-4 | UNII_Ref = | UNII = 40S1VHN69B | PubChem = 5460769…

{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 401932982 | image = Bleomycin A2.svg | image_class = skin-invert-image | caption = Bleomycin A2 | width = 350 | alt = | pronounce = | tradename = Blenoxane | Drugs.com = | MedlinePlus = a682125 | DailyMedID = Bleomycin | pregnancy_AU = D | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = intravenous, intramuscular, subcutaneous, intrapleural | class = Glycopeptide antibiotic | ATC_prefix = L01 | ATC_suffix = DC01 | ATC_supplemental = | legal_AU = S4 | legal_AU_comment = | legal_BR = | legal_BR_comment = | legal_CA = | legal_CA_comment = | legal_DE = | legal_DE_comment = | legal_NZ = | legal_NZ_comment = | legal_UK = POM | legal_UK_comment = | legal_US = Rx-only | legal_US_comment = | legal_EU = Rx-only | legal_EU_comment = | legal_UN = | legal_UN_comment = | legal_status = | bioavailability = 100% and 70% following intramuscular and subcutaneous administrations, respectively, and 45% following both intraperitoneal and intrapleural administrations | protein_bound = | metabolism = | metabolites = | onset = | elimination_half-life = two hours | duration_of_action = | excretion = Kidney (60–70%) | index_label = | index2_label = sulfate | CAS_number_Ref = | CAS_number = 11056-06-7 | CAS_number2_Ref = | CAS_number2 = 9041-93-4 | UNII_Ref = | UNII = 40S1VHN69B | PubChem = 5460769 | IUPHAR_ligand = | DrugBank_Ref = | DrugBank = DB00290 | ChemSpiderID_Ref = | ChemSpiderID = 4574226 | UNII2_Ref = | UNII2 = 7DP3NTV15T | KEGG_Ref = | KEGG = D07535 | KEGG2_Ref = | KEGG2 = C15773 | ChEBI_Ref = | ChEBI = 22907 | ChEMBL_Ref = | ChEMBL = 403664 | NIAID_ChemDB = | PDB_ligand = | synonyms = | IUPAC_name = (3- [(2'- (5S,8S,9S,10R,13S)-15- 6-amino-2- [(1S)-3-amino-1- [(2S)-2,3-diamino-3-oxopropyl]amino}-3-oxopropyl] -5-methylpyrimidin-4-yl}-13-[{[(2R,3S,4S,5S,6S)-3- {[(2R,3S,4S,5R,6R)-4-(carbamoyloxy)-3,5-dihydroxy-6- (hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy} -4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy} (1H-imidazol-5-yl)methyl]-9-hydroxy-5-[(1R)-1-hydroxyethyl]-8,10-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazapentadec-1-yl}-2,4'-bi-1,3-thiazol-4-yl)carbonyl]amino}propyl)(dimethyl)sulfonium | C=55 | H=84 | N=17 | O=21 | S=3 | SMILES = CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H](C(C2=CN=CN2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O | StdInChI_Ref = | StdInChI = 1S/C55H83N17O21S3/c1-20-33(69-46(72-44(20)58)25(12-31(57)76)64-13-24(56)45(59)82)50(86)71-35(41(26-14-61-19-65-26)91-54-43(39(80)37(78)29(15-73)90-54)92-53-40(81)42(93-55(60)88)38(79)30(16-74)89-53)51(87)66-22(3)36(77)21(2)47(83)70-34(23(4)75)49(85)63-10-8-32-67-28(18-94-32)52-68-27(17-95-52)48(84)62-9-7-11-96(5)6/h14,17-19,21-25,29-30,34-43,53-54,64,73-75,77-81H,7-13,15-16,56H2,1-6H3,(H13-,57,58,59,60,61,62,63,65,66,69,70,71,72,76,82,83,84,85,86,87,88)/p+1/t21-,22+,23+,24-,25-,29-,30+,34-,35-,36-,37+,38+,39-,40-,41-,42-,43-,53+,54-/m0/s1 | StdInChI_comment = | StdInChIKey_Ref = | StdInChIKey = OYVAGSVQBOHSSS-UAPAGMARSA-O | density = | density_notes = | melting_point = | melting_high = | melting_notes = | boiling_point = | boiling_notes = | solubility = | sol_units = | specific_rotation = }} Bleomycin is a medication primarily used to treat cancer. This includes Hodgkin's lymphoma, non-Hodgkin's lymphoma, testicular cancer, ovarian cancer, and cervical cancer among others. Typically used with other cancer medications, it can be given intravenously, by injection into a muscle or under the skin. It may also be administered inside the chest to help prevent the recurrence of a pleural effusion due to cancer; however, talc is better for this. It may sometimes be used to treat other difficult-to-treat skin lesions such as plantar warts in immunocompromised patients. Common side effects include fever, weight loss, vomiting, and rash. A severe type of anaphylaxis may occur. It may also cause inflammation of the lungs that can result in lung scarring. Chest X-rays every couple of weeks are recommended to check for this. Bleomycin may cause harm to the baby if used during pregnancy. It is believed to primarily work by preventing the synthesis of DNA. Bleomycin was discovered in 1962. It is on the World Health Organization's List of Essential Medicines. It is available as a generic medication. It is made by the bacterium Streptomyces verticillus.

Medical uses

Cancer

Bleomycin is mostly used to treat testicular cancer, ovarian cancer, and Hodgkin's disease, and less commonly non-Hodgkin's disease. It can be given intravenously, by intramuscular injection, or under the skin.

Other uses

It may also be put inside the chest to help prevent the recurrence of a pleural effusion due to cancer. However, for scarring down the pleura, talc appears to be the better option although indwelling pleural catheters are at least as effective in reducing the symptoms of an effusion(such as dyspnea). While potentially effective against bacterial infections, its toxicity prevents its use for this purpose. It has been studied in the treatment of warts but is of unclear benefit.

Research

Bleomycin is used in research to induce pulmonary fibrosis in mice.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1376179398 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

12 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.